New Approaches to the Treatment of Migraine: Clinical and Economic Impact

Advertisement

---

Participating Faculty

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Introduction

Lisa K. Mannix, MD

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Migraine: Diagnosis, Management, and New Treatment Options

R. Michael Gallagher, DO;F. Michael Cutrer, MD

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability

Randal L. Von Seggern, PharmD, BCPS

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Economic Comparison of Oral Triptans for Management of Acute Migraine: Implications for Managed Care

C.E. Reeder, RPh, PhD;Sharm Steadman, PharmD, BCPS, FASHP;Scott D. Goldfarb, PharmD, MBA

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Health Outcomes Evaluations: Estimating the Impact of Almotriptan in Managed Care Settings

Kevin W. Mayo, PhD;Jane T. Osterhaus, PhD

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Almotriptan Versus Sumatriptan in Migraine Treatment: Direct Medical Costs of Managing Adverse Chest Symptoms

Lisa K. Mannix, MD;James U. Adelman, MD, FACP;Scott D. Goldfarb, PharmD, MBA;Randal L. Von Seggern, PharmD, BCPS;Chris M. Kozma, PhD

February 1st 2002

ArticleSUPPLEMENT CONTENT

---

Cost Savings in Migraine Associated with Less Chest Pain on New Triptan Therapy

Joseph T. Wang, MS;Charles E. Barr, MD;Yas Torigoe, PhD;Elaine Wang, BS;Clayton R. Rowland, PhD;Scott D. Goldfarb, PharmD, MBA

February 1st 2002

ArticleSUPPLEMENT CONTENT